26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Sequence Analysis of Antimicrobial <strong>Peptide</strong>s 45<br />

14. To achieve a faster separation it is also possible to start the gradient earlier to<br />

compensate the dead volume between the gradient mixer and the trap column.<br />

On our instrument we have a dead volume of about 1.3 �L. At a flow rate of 300<br />

nL/min we start the gradient 4 min before the valve switches.<br />

15. Due to the high sensitivity it is favorably to couple a nanoHPLC to an ESI-source.<br />

As mass spectrometers are concentration dependent detectors, the sensitivity of<br />

an instrumental setup is mostly determined by the peptide concentration of the<br />

eluate but not by the peptide amount. Thus a nanocolumn with a flow rate of<br />

300 nL/min provides an about thousand times higher sensitivity than a microbore<br />

column with a flow rate of 300 �L/min. As an alternative to buying a nanoHPLC<br />

system it is also possible to use a relatively inexpensive flow splitter after the<br />

pump and before the injection valve and the column. Thereby the flow rate can<br />

be reduced to use a capillary column (flow rate 4 �L/min) on an analytical HPLC<br />

system or a nanocolumn on a capillary HPLC system. Instead of a flow-splitter<br />

it is preferred to couple a nanoHPLC to an ESI-source. Thereby, the flow rate<br />

is split according to the column backpressure, i.e., mostly the column volumes<br />

if the same packing materials are used. However, these low-cost setups are less<br />

reliable than a nanoHPLC and the reproducibility is worse.<br />

16. Alternative to DDA, the term “information-dependent acquisition” (IDA) is used.<br />

Both DDA and IDA describe an automatic mode where the MS/MS parameters<br />

are collected automatically by calculating the parameter set (e.g., collision<br />

energy) based on the mass and charge state of the selected precursor ion.<br />

17. The described conditions alkylate cysteine residues almost quantitatively, even<br />

for defensins, which contain three disulfide bonds. Higher temperatures (>37 ◦ C)<br />

and longer reaction times (> 1 h) do not further increase the cysteine<br />

alkylation but may produce further byproducts, such as carboxymethyllysine<br />

(CML).<br />

18. Despite the high lysine and arginine content of most antimicrobial peptides,<br />

tryptic digests typically yield medium-sized peptides, as often a proline residue<br />

follows these basic residues eliminating the cleavage site.<br />

19. Prepare a fresh OME solution for every reaction. Storage of this solution reduces<br />

the guanidination degree of the lysine residues significantly yielding heterogeneous<br />

samples. To process several samples in parallel prepare a larger volume of<br />

the solvent (i.e., 30 �L water, 20 �L 0.1% TFA, and 55 �L ammonium hydroxide<br />

solution) and dissolve the O-methylisourea hemisulfate (2.55 mg/51 mL in Tris-<br />

HCl buffer) just before the guanidation reaction is started, add 15 �L tothe<br />

solvent solution. Add 12 �L to each dried peptide.<br />

20. Do not press the tip of a ZipTip TM on the bottom of a polypropylene vial or any<br />

other surface, as the packing material might break and block the tip. Also remove<br />

it carefully with a pair of tweezers and mount it on the pipette by touching the<br />

ZipTip TM only on the top.<br />

21. Even if a modified peptide was only detected in negative ion mode it is still<br />

possible to record a tandem mass spectrum with reasonable signal intensities in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!